Melanoma cells, the most aggressive form of skin cancer, produce a protein that blocks the recognition and removal of the ...

Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...

The results showed that patients receiving the vaccine had significant immune activity ... HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer, npj ...

For glioblastoma, several strategies have been developed to enhance the immune response against cancers: Monoclonal ...

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

CERo’s technology works by grafting onto patients’ own T-cells a receptor that binds to a naturally occurring human antigen that is upregulated in cancer cells.

Tertiary lymphoid structures (TLS) are increasingly recognized to have roles in cancer. Within tumor microenvironments (TME), TLS can arise as ectopic lymphoid organs containing aggregates of ...

More recently, a small population of cells -- the RORγt+ dendritic cells -- has been found among the gut's presenting immune cells in multiple species. Colonna's lab was the first to identify the ...

By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center for Cancer Biology and their collaborators demonstrated a remarkable ability to boost the immune system's fight ...